Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CENTER FOR RIDEFYSIOTERAPI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.0%   Bankruptcy risk   2.7% 2.4% 2.9% 3.2% 2.7% 2.8% 20.4% 17.2%   Credit score (0-100)   62 65 58 54 60 59 5 10   Credit rating   BBB BBB BBB BBB BBB BBB B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,881 2,818 2,269 2,940 2,852 3,363 0.0 0.0   EBITDA   912 700 215 724 448 691 0.0 0.0   EBIT   500 277 -150 367 90.3 259 0.0 0.0   Pre-tax profit (PTP)   259.9 97.8 -336.0 178.9 -138.2 -64.1 0.0 0.0   Net earnings   202.9 72.1 -249.3 139.9 -240.2 -66.1 0.0 0.0   Pre-tax profit without non-rec. items   260 97.8 -336 179 -138 -64.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   11,414 11,323 10,952 10,656 10,520 10,348 0.0 0.0   Shareholders equity total   -230 -158 -407 -268 -508 -574 -654 -654   Interest-bearing liabilities   6,896 7,905 7,848 7,713 7,915 8,248 654 654   Balance sheet total (assets)   12,217 11,822 11,574 11,385 11,285 10,751 0.0 0.0   Net Debt   6,896 7,905 7,848 7,713 7,915 8,248 654 654     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,881 2,818 2,269 2,940 2,852 3,363 0.0 0.0   Gross profit growth   23.1% -2.2% -19.5% 29.5% -3.0% 17.9% -100.0% 0.0%   Employees   0 0 0 0 0 10 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   12,217 11,822 11,574 11,385 11,285 10,751 0 0   Balance sheet change%   1.6% -3.2% -2.1% -1.6% -0.9% -4.7% -100.0% 0.0%   Added value   911.9 699.9 215.2 724.2 447.4 690.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -458 -514 -736 -653 -493 -605 -10,348 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   17.4% 9.8% -6.6% 12.5% 3.2% 7.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.0% 2.3% -1.2% 3.1% 0.8% 2.2% 0.0% 0.0%   ROI %   5.5% 3.2% -1.8% 4.5% 1.1% 3.1% 0.0% 0.0%   ROE %   1.7% 0.6% -2.1% 1.2% -2.1% -0.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -1.9% -1.3% -3.4% -2.3% -4.3% -5.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   756.2% 1,129.5% 3,647.5% 1,065.0% 1,766.4% 1,194.1% 0.0% 0.0%   Gearing %   -2,994.3% -4,996.6% -1,926.2% -2,883.0% -1,558.9% -1,437.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.4% 2.4% 2.4% 2.4% 2.9% 4.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0   Current Ratio   0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.0   Cash and cash equivalent   0.6 0.3 0.8 0.0 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,717.3 -4,077.4 -4,752.3 -4,915.2 -4,715.1 -5,263.1 -326.9 -326.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 69 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 69 0 0   EBIT / employee   0 0 0 0 0 26 0 0   Net earnings / employee   0 0 0 0 0 -7 0 0